Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
BSF Enterprise PLC on Thursday said it had successfully created proof-of-concept cultivated leather products for one of its partners.
The London-based biotech investor has received £90,000 in payments to date for the development of alternative leather samples.
In 2023, its subsidiary UK tissue engineering company, 3D-Bio Tissues Ltd, agreed to provide bioengineered samples of animal skin tissues to an unnamed ‘major multinational leather fashion company’ for £50,000.
Following a 60-week study, 3D-Bio achieved the technical and operational requirements of the deal and is currently working towards other similar projects.
BSF Managing Director Che Connon said: ‘We look forward to seeing these commercial and research partnerships continue to grow as we increase our production capacity to enable further development of cultivated skin on a larger scale to meet the growing demand.’
The company was also awarded £38,000 in grant funding from the UK government to embark on a project with the University of Northampton to create sustainable and ethical alternatives to leather.
BSF shares were down 9.6% to 5.65 pence each in London on Thursday morning.
Copyright 2024 Alliance News Ltd. All Rights Reserved.